• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒和 SARS-COV-2。

Coronaviruses and SARS-COV-2.

机构信息

Department of Virology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpaşa, İstanbul, Turkey

Microbiology Reference Lab and Biological Products Department, General Directorate of Public Health Department, Republic of Turkey Ministry of Health, Ankara, Turkey

出版信息

Turk J Med Sci. 2020 Apr 21;50(SI-1):549-556. doi: 10.3906/sag-2004-127.

DOI:10.3906/sag-2004-127
PMID:32293832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7195990/
Abstract

Coronaviruses (CoVs) cause a broad spectrum of diseases in domestic and wild animals, poultry, and rodents, ranging from mild to severe enteric, respiratory, and systemic disease, and also cause the common cold or pneumonia in humans. Seven coronavirus species are known to cause human infection, 4 of which, HCoV 229E, HCoV NL63, HCoV HKU1 and HCoV OC43, typically cause cold symptoms in immunocompetent individuals. The others namely SARS-CoV (severe acute respiratory syndrome coronavirus), MERS-CoV (Middle East respiratory syndrome coronavirus) were zoonotic in origin and cause severe respiratory illness and fatalities. On 31 December 2019, the existence of patients with pneumonia of an unknown aetiology was reported to WHO by the national authorities in China. This virus was officially identified by the coronavirus study group as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the present outbreak of a coronavirus-associated acute respiratory disease was labelled coronavirus disease 19 (COVID-19). COVID-19’s first cases were seen in Turkey on March 10, 2020 and was number 47,029 cases and 1006 deaths after 1 month. Infections with SARS-CoV-2 are now widespread, and as of 10 April 2020, 1,727,602 cases have been confirmed in more than 210 countries, with 105,728 deaths.

摘要

冠状病毒(CoVs)可引起家养和野生动物、家禽和啮齿动物的广泛疾病谱,从轻度到严重的肠道、呼吸道和全身性疾病,还可引起人类普通感冒或肺炎。已知有 7 种冠状病毒可引起人类感染,其中 4 种,即 HCoV 229E、HCoV NL63、HCoV HKU1 和 HCoV OC43,通常在免疫功能正常的个体中引起感冒症状。其他的,即 SARS-CoV(严重急性呼吸综合征冠状病毒)、MERS-CoV(中东呼吸综合征冠状病毒),则源于人畜共患病,可引起严重的呼吸道疾病和死亡。2019 年 12 月 31 日,中国国家当局向世卫组织报告了存在病因不明的肺炎患者。该病毒被冠状病毒研究小组正式鉴定为严重急性呼吸综合征冠状病毒 2(SARS-CoV-2),目前与冠状病毒相关的急性呼吸道疾病爆发被命名为冠状病毒病 19(COVID-19)。COVID-19 的首例病例于 2020 年 3 月 10 日在土耳其出现,1 个月后确诊病例达到 47029 例,死亡 1006 例。目前,SARS-CoV-2 的感染已广泛传播,截至 2020 年 4 月 10 日,在 210 多个国家已确诊超过 1727602 例病例,死亡 105728 例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/98cf31af784b/turkjmedsci-50-549-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/98cf31af784b/turkjmedsci-50-549-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/71f53fe08aa6/turkjmedsci-50-549-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/8b8d51d98298/turkjmedsci-50-549-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/98cf31af784b/turkjmedsci-50-549-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/98cf31af784b/turkjmedsci-50-549-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/71f53fe08aa6/turkjmedsci-50-549-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/8b8d51d98298/turkjmedsci-50-549-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/644c/7195990/98cf31af784b/turkjmedsci-50-549-fig001.jpg

相似文献

1
Coronaviruses and SARS-COV-2.冠状病毒和 SARS-COV-2。
Turk J Med Sci. 2020 Apr 21;50(SI-1):549-556. doi: 10.3906/sag-2004-127.
2
Properties of Coronavirus and SARS-CoV-2.冠状病毒及新型冠状病毒(SARS-CoV-2)的特性
Malays J Pathol. 2020 Apr;42(1):3-11.
3
Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.新型冠状病毒(SARS-CoV-2)的祖先起源、抗原相似性和流行病学见解:全球负担和孟加拉国视角。
Infect Genet Evol. 2020 Oct;84:104440. doi: 10.1016/j.meegid.2020.104440. Epub 2020 Jul 1.
4
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.
5
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.紫锥菊制剂 Echinaforce®抗冠状病毒(包括普通感冒冠状病毒 229E 和 SARS-CoV-2)的体外病毒杀灭活性。
Virol J. 2020 Sep 9;17(1):136. doi: 10.1186/s12985-020-01401-2.
6
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.新型严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)的爆发:当前全球状况综述。
J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4.
7
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
8
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.冠状病毒发病机制的分子基础:以比较基因组学方法研究行星健康,以预防 21 世纪的人畜共患病爆发。
OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16.
9
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.HTCC 作为 SARS-CoV-2 和 MERS-CoV 的聚合抑制剂。
J Virol. 2021 Jan 28;95(4). doi: 10.1128/JVI.01622-20.
10
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.

引用本文的文献

1
Immune factors produced by PBMCs upon stimulation with lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1-derived exopolysaccharides inhibit HCoV-229E and SARS-CoV-2 replication.经德氏保加利亚乳杆菌OLL1073R-1衍生的胞外多糖刺激后,外周血单核细胞产生的免疫因子可抑制人冠状病毒229E和严重急性呼吸综合征冠状病毒2的复制。
Sci Rep. 2025 Aug 27;15(1):31621. doi: 10.1038/s41598-025-17308-3.
2
Evaluating the MT-CYB and MT-ATP6 variations in COVID-19 patients: A case-control study.评估新冠肺炎患者中MT-CYB和MT-ATP6基因变异:一项病例对照研究。
PLoS One. 2025 Aug 21;20(8):e0329866. doi: 10.1371/journal.pone.0329866. eCollection 2025.
3

本文引用的文献

1
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.雪貂、猫、狗和其他驯养动物对 SARS-CoV-2 的易感性。
Science. 2020 May 29;368(6494):1016-1020. doi: 10.1126/science.abb7015. Epub 2020 Apr 8.
2
Zoonotic origins of human coronaviruses.人畜共患起源的人类冠状病毒。
Int J Biol Sci. 2020 Mar 15;16(10):1686-1697. doi: 10.7150/ijbs.45472. eCollection 2020.
3
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.与严重急性呼吸综合征冠状病毒1(SARS-CoV-1)相比,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在气溶胶和表面的稳定性
Recent Advances in Micro- and Nano-Enhanced Intravascular Biosensors for Real-Time Monitoring, Early Disease Diagnosis, and Drug Therapy Monitoring.
用于实时监测、疾病早期诊断和药物治疗监测的微纳增强型血管内生物传感器的最新进展
Sensors (Basel). 2025 Aug 7;25(15):4855. doi: 10.3390/s25154855.
4
Evaluating the distribution and clustering of SARS-CoV-2 antibodies in dogs across the United States of America.评估美国各地犬类中新型冠状病毒2型抗体的分布和聚集情况。
Sci Rep. 2025 Jul 1;15(1):21758. doi: 10.1038/s41598-025-06730-2.
5
Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development.冠状病毒反向遗传系统的发展:发病机制研究及疫苗/药物研发的核心技术
Virulence. 2025 Dec;16(1):2525930. doi: 10.1080/21505594.2025.2525930. Epub 2025 Jun 28.
6
Practical Challenges in the Diagnosis of SARS-CoV-2 Infection in Children.儿童新冠病毒感染诊断中的实际挑战
Nurs Rep. 2025 May 30;15(6):196. doi: 10.3390/nursrep15060196.
7
Meta-transcriptomics Reveals Dysbiosis of the Respiratory Microbiome in Older Adults with Long COVID.宏转录组学揭示了长期新冠病毒感染的老年人呼吸道微生物群的失调。
Research (Wash D C). 2025 Jun 2;8:0720. doi: 10.34133/research.0720. eCollection 2025.
8
A label-free nanowell-based impedance sensor for ten-minute SARS-CoV-2 detection.一种用于十分钟内检测新型冠状病毒(SARS-CoV-2)的基于纳米孔的无标记阻抗传感器。
Sens Diagn. 2025 Apr 30. doi: 10.1039/d5sd00002e.
9
Screening of Bovine Coronavirus Multiepitope Vaccine Candidates: An Immunoinformatics Approach.牛冠状病毒多表位疫苗候选物的筛选:一种免疫信息学方法。
Transbound Emerg Dis. 2024 Jul 18;2024:5986893. doi: 10.1155/2024/5986893. eCollection 2024.
10
Viral Transmission in Sea Food Systems: Strategies for Control and Emerging Challenges.海产品系统中的病毒传播:控制策略与新出现的挑战
Foods. 2025 Mar 20;14(6):1071. doi: 10.3390/foods14061071.
N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.
4
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species.新型冠状病毒和其他物种冠状病毒的遗传进化分析。
Infect Genet Evol. 2020 Aug;82:104285. doi: 10.1016/j.meegid.2020.104285. Epub 2020 Mar 10.
5
Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.空气、表面环境和个人防护设备被 SARS-CoV-2(严重急性呼吸综合征冠状病毒 2)污染:来自有症状患者的证据。
JAMA. 2020 Apr 28;323(16):1610-1612. doi: 10.1001/jama.2020.3227.
6
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
7
Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.SARS-CoV-2 的进化史、潜在的中间宿主动物及种间分析。
J Med Virol. 2020 Jun;92(6):602-611. doi: 10.1002/jmv.25731. Epub 2020 Mar 11.
8
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.SARS-CoV-2 及其他 B 属β冠状病毒的细胞进入和受体使用功能评估。
Nat Microbiol. 2020 Apr;5(4):562-569. doi: 10.1038/s41564-020-0688-y. Epub 2020 Feb 24.
9
Virus Isolation from the First Patient with SARS-CoV-2 in Korea.韩国首例 SARS-CoV-2 患者的病毒分离。
J Korean Med Sci. 2020 Feb 24;35(7):e84. doi: 10.3346/jkms.2020.35.e84.
10
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.